Clinical trial · Observational
Efficacy of Endoscopic Band Ligation (DEBL) for Duodenal Neuroendocrine Neoplasms(dNENs)
Efficacy of Endoscopic Band Ligation (DEBL) for Duodenal Neuroendocrine Neoplasms(dNENs) : A Prospective Study
NCT06790056CI-TRIAL-00084993DEBLcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary objective To evaluate the therapeutic efficacy (clinical success) of dEBL at 3 months 2b. Secondary objective To evaluate adverse events, technical success and recurrence on follow-up 50 patients over 1-year duration based on our previous study of Prospective data (2023-2024)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Duodenal Neuroendocrine Tumor | Duodenal Neuroendocrine Tumor | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| duodenal ndoscopic bind ligation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Duodenal endoscopic band ligation group
- description
- We will collect your basic demographics details like age, Sex, date of admission, Endoscopy (is a test to look inside your body) details of Site, size, number of lesion. By EUS (Endoscopic ultrasound (EUS) combines two techniques - endoscopy and ultrasound - to help doctors see, evaluate and diagnose conditions in and near the gastrointestinal (GI) tract) details of layer of Duodenum involved, site/size/number of lesions. We will collect your details of Duodenal endoscopic band ligation procedure to check feasibility, technical success. You are requested to come for follow up for 3 months for endoscopy prodecure.
- interventionNames
- Procedure: duodenal ndoscopic bind ligation
Primary outcomes (1)
- measure
- Therapeutic efficacy (clinical success) of dEBL at 3 months and 1 year
- timeFrame
- One year
- description
- Therapeutic efficacy (clinical success) of dEBL at 3 months and 1 year
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Patients age \>18 years * Size of lesion less than 15mm * Site of lesion- duodenum (d1-d4) * No of lesions- ≤6 Exclusion Criteria: * Age less than 18 years * Non-duodenal lesion * Local or distant metastasis * Lumen occluding lesions * Uncorrectable coagulopathy * Not willing for consent
References
Publications (0)
Data not yet available
No reference posted for this study.